-
Cy5 maleimide (non-sulfonated): Technical Guide for Protein
2026-05-23
Cy5 maleimide (non-sulfonated) enables selective, covalent fluorescent labeling of cysteine-containing proteins and peptides through thiol-reactive chemistry. Its high extinction coefficient supports sensitive detection in fluorescence-based imaging and assay workflows, but low aqueous solubility requires protocols incorporating organic co-solvents. This reagent should not be used in water-only labeling conditions or applications lacking cysteine targets.
-
Applied Use of 5-Aminolevulinic acid HCl in Heme Biosynthesi
2026-05-22
5-Aminolevulinic acid HCl enables precise, reproducible modulation of heme biosynthesis in studies of bacterial virulence and immune evasion. This article details optimized workflows, protocol parameters, and troubleshooting strategies for both pathogen-focused and translational cancer research settings.
-
Capsaicin: Beyond TRPV1—Epigenetic and Translational Insight
2026-05-22
Explore how Capsaicin ((E)-Capsaicin) advances research beyond TRPV1 ion channel activation, with new insights into epigenetic modulation and translational pain models. This article reveals deeper mechanisms and practical guidance for next-generation assay design.
-
Topotecan in Recurrent SCLC: Clinical Update and Research In
2026-05-21
This article reviews the pivotal update on Topotecan's clinical use in recurrent small cell lung cancer (SCLC), highlighting its efficacy, safety, and role in symptom palliation. The findings are contextualized with current research workflows and practical experimental considerations.
-
GPC3-HSP70 mRNA Nanovaccine and PD-L1 Blockade in HCC Immuni
2026-05-21
This study presents a novel mRNA nanovaccine encoding glypican-3 CTL epitopes fused with HSP70 and demonstrates that its combination with anti-PD-L1 therapy elicits robust T-cell-mediated immunity against hepatocellular carcinoma. The findings highlight advances in rational antigen design, targeted mRNA delivery, and the synergistic potential of combining mRNA vaccination with immune checkpoint blockade.
-
Mubritinib (TAK 165): Advanced Workflows in AML Research
2026-05-20
Mubritinib (TAK 165) empowers researchers to dissect oxidative phosphorylation dependencies in chemotherapy-resistant AML and KSHV-driven lymphoma models. With unique selectivity for mitochondrial complex I, this APExBIO compound delivers workflow flexibility and targeted cytotoxicity that surpasses traditional HER2 inhibitors.
-
Applied Workflows with the Alcian Blue & Nuclear Fast Red St
2026-05-20
Unlock robust mucopolysaccharide detection and chondrogenic differentiation analysis with the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5. Explore streamlined protocols, advanced troubleshooting, and expert insights for histological precision—powered by APExBIO.
-
Mavorixafor Hydrochloride: Selective CXCR4 Antagonist Benchm
2026-05-19
Mavorixafor hydrochloride (AMD-070 hydrochloride) is a potent, selective CXCR4 antagonist with proven efficacy in WHIM syndrome and key roles in modulating immune cell trafficking. Clinical data show it increases neutrophil and lymphocyte counts and substantially reduces infection rates, with a favorable safety profile. This article reviews its mechanism, clinical benchmarks, and integration in advanced research workflows.
-
Biomimetic Chromatography Advances Pulmonary Drug Permeabili
2026-05-19
The reference study systematically evaluates biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane chromatography (IAM-LC), each coupled with mass spectrometry, for modeling lung permeability of pharmaceuticals. By benchmarking these platforms against established physicochemical descriptors and leveraging high-throughput detection, the study highlights their complementary strengths and practical implications for respiratory drug development.
-
Evaluating Dye Strategies for Small Tissue Biopsy Preservati
2026-05-18
This article examines a recent study comparing the effectiveness of various dyes—including hematoxylin and alcian blue—in improving the visibility and preservation of small tissue biopsies during pathology processing. The research highlights protocol refinements that optimize tissue recognition while minimizing diagnostic interference, with direct implications for histological staining workflows.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody: Workflow Guidance
2026-05-18
The FITC Goat Anti-Mouse IgG (H+L) Antibody enables sensitive and specific detection of mouse IgG in immunofluorescence, flow cytometry, and microscopy assays. It is not intended for use with non-mouse primaries or in non-fluorescent protocols. Careful adherence to storage, handling, and workflow parameters ensures reproducibility and optimal signal detection.
-
Tetrahedral DNA Nanostructures Advance Enzymatic DNA Synthes
2026-05-17
This study demonstrates that highly ordered tetrahedral DNA nanostructures (TDN) significantly enhance enzymatic oligonucleotide synthesis (EOS) by improving enzyme accessibility and reducing synthesis errors. The findings have major implications for DNA synthesis efficiency, fidelity, and future applications in DNA storage and molecular biology.
-
Indometacin Sodium Trihydrate: Precision Tools for Inflammat
2026-05-16
Indometacin Sodium Trihydrate, available from APExBIO, delivers exceptional reproducibility in inflammation, cell differentiation, and neuroregeneration workflows. Its validated use in COX inhibition, prostaglandin synthesis modulation, and myelin repair positions it as a keystone for anti-inflammatory research and translational applications.
-
Cell Counting Kit-8 Plus: Powering Translational Discovery
2026-05-15
Explore how the advanced Cell Counting Kit-8 (CCK-8) Plus empowers translational researchers with sensitive and robust cell viability assays. We blend mechanistic insights, recent peer-reviewed findings, and strategic guidance for optimizing cell proliferation and cytotoxicity workflows. Drawing on the latest science—including landmark studies in inflammation and drug screening—we position APExBIO's CCK-8 Plus as the next-generation solution for bridging preclinical rigor and clinical impact.
-
Bisphenol A Exposure Drives AAA: Multi-Omics Mechanistic Ana
2026-05-15
This study establishes a causal link between environmental Bisphenol A (BPA) exposure and abdominal aortic aneurysm (AAA) development by integrating cross-scale exposure modeling with in vivo and multi-omics validation. The findings highlight key molecular pathways and cellular targets, providing new prognostic markers and actionable research directions for cardiovascular disease risk assessment.